Baird Initiates Coverage On Privia Health Gr with Outperform Rating, Announces Price Target of $23
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Michael Ha has initiated coverage on Privia Health Group (NASDAQ:PRVA) with an Outperform rating and set a price target of $23.
May 30, 2024 | 10:06 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Baird analyst Michael Ha has initiated coverage on Privia Health Group with an Outperform rating and a price target of $23. This positive analyst rating could boost investor confidence and potentially drive the stock price up in the short term.
The initiation of coverage with an Outperform rating and a specific price target of $23 by a reputable analyst can positively influence investor sentiment. This could lead to increased buying activity and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100